Circulating levels of interleukin-17A, tumor necrosis factor-alpha, interleukin-18, interleukin-10, and cognitive performance of patients with relapsing-remitting multiple sclerosis

References

• DeLuca GC, Yates RL, Beale H, et al. Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights. Brain Pathol. 2015;25(1):79–98.10.1111/bpa.2015.25.issue-1
   PubMed Web of Science ®Google Scholar
• Pflugshaupt T, Geisseler O, Nyffeler T, et al. Cognitive impairment in multiple sclerosis: clinical manifestation, neuroimaging correlates, and treatment. Semin Neurol. 2016;36(2):203–211.
   PubMed Web of Science ®Google Scholar
• Achiron A, Chapman J, Magalashvili D, et al. Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study. PLoS One. 2013 [cited 2013 Aug 1]; [10p.]. DOI:10.1371/journal.pone.0071058.
   Web of Science ®Google Scholar
• Yirmiya R, Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun. 2011;25(2):181–213.10.1016/j.bbi.2010.10.015
   PubMed Web of Science ®Google Scholar
• Schwartz M, Kipnis J, Rivest S, et al. How do immune cells support and shape the brain in health, disease, and aging? J Neurosci. 2013;33(45):17587–17596.10.1523/JNEUROSCI.3241-13.2013
   PubMed Web of Science ®Google Scholar
• Donzis EJ, Tronson NC. Modulation of learning and memory by cytokines: signaling mechanisms and long term consequences. Neurobiol Learn Mem. 2014;115:68–77.10.1016/j.nlm.2014.08.008
   PubMed Web of Science ®Google Scholar
• Goshen I, Avital A, Kreisel T, et al. Environmental enrichment restores memory functioning in mice with impaired IL-1 signaling via reinstatement of long-term potentiation and spine size enlargement. J Neurosci. 2009;29(11):3395–3403.10.1523/JNEUROSCI.5352-08.2009
   PubMed Web of Science ®Google Scholar
• Wu MD, Hein AM, Moravan MJ, et al. Adult murine hippocampal neurogenesis is inhibited by sustained IL-1β and not rescued by voluntary running. Brain Behav Immun. 2012;26(2):292–300.10.1016/j.bbi.2011.09.012
   PubMed Web of Science ®Google Scholar
• Zunszain PA, Anacker C, Cattaneo A, et al. Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology 2012;37(4):939–949.10.1038/npp.2011.277
   PubMed Web of Science ®Google Scholar
• Chen Z, Palmer TD. Differential roles of TNFR1 and TNFR2 signaling in adult hippocampal neurogenesis. Brain Behav Immun. 2013;30:45–53.10.1016/j.bbi.2013.01.083
   PubMed Web of Science ®Google Scholar
• Simpson EE, Hodkinson CF, Maylor EA, et al. Intracellular cytokine production and cognition in healthy older adults. Psychoneuroendocrinology 2013;38(10):2196–2208.10.1016/j.psyneuen.2013.04.007
   PubMed Web of Science ®Google Scholar
• Liu YH, Zeng F, Wang YR, et al. Immunity and Alzheimer’s disease: immunological perspectives on the development of novel therapies. Drug Discov Today. 2013;18(23–24):1212–1220.10.1016/j.drudis.2013.07.020
   PubMed Web of Science ®Google Scholar
• Chen JM, Jiang GX, Li QW, et al. Increased serum levels of interleukin-18, -23 and -17 in Chinese patients with Alzheimer’s disease. Dement Geriatr Cogn Disord. 2014;38(5–6):321–329.10.1159/000360606
   PubMed Web of Science ®Google Scholar
• Hilsabeck RC, Anstead GM, Webb AL, et al. Cognitive efficiency is associated with endogenous cytokine levels in patients with chronic hepatitis C. J Neuroimmunol. 2010;221:53–61.10.1016/j.jneuroim.2010.01.017
   PubMed Web of Science ®Google Scholar
• Richwine AF, Sparkman NL, Dilger RN, et al. Cognitive deficits in interleukin-10-deficient mice after peripheral injection of lipopolysaccharide. Brain Behav Immun. 2009;23(6):794–802.10.1016/j.bbi.2009.02.020
   PubMed Web of Science ®Google Scholar
• Derecki NC, Cardani AN, Yang CH, et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med. 2010;207:1067–1080.10.1084/jem.20091419
   PubMed Web of Science ®Google Scholar
• Meyer U, Nyffeler M, Engler A, et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci. 2006;26(18):4752–4762.10.1523/JNEUROSCI.0099-06.2006
   PubMed Web of Science ®Google Scholar
• Meyer U, Murray PJ, Urwyler A, et al. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry. 2008;13(2):208–221.10.1038/sj.mp.4002042
   PubMed Web of Science ®Google Scholar
• Kallaur AP, Oliveira SR, Simão AN, et al. Cytokine profile in relapsing-remitting multiple sclerosis patients and the association between progression and activity of the disease. Mol Med Rep. 2013;7:1010–1020.10.3892/mmr.2013.1256
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302.10.1002/ana.22366
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–1444.10.1212/WNL.33.11.1444
   PubMed Web of Science ®Google Scholar
• Papathanasiou A, Messinis L, Georgiou VL, et al. Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening battery. ISRN Neurol. 2014 [cited 2014 Mar 13]; [7 p.]. DOI:10.1155/2014/151379.
   Google Scholar
• Cáceres F, Vanotti S, Rao S, et al. Epidemiological characteristics of cognitive impairment of multiple sclerosis patients in a Latin American country. J Clin Exp Neuropsychol. 2011;33(10):1094–1098.10.1080/13803395.2011.603690
   PubMed Web of Science ®Google Scholar
• Patanella AK, Zinno M, Quaranta D, et al. Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients. J Neurosci Res. 2010;88(5):1106–1112.
   PubMed Web of Science ®Google Scholar
• Acharjee S, Nayani N, Tsutsui M, et al. Altered cognitive-emotional behavior in early experimental autoimmune encephalitis – cytokine and hormonal correlates. Brain Behav Immun. 2013;33:164–172.10.1016/j.bbi.2013.07.003
   PubMed Web of Science ®Google Scholar
• Dutra RC, Moreira EL, Alberti TB, et al. Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: the role of Kallikrein–Kinin system. Brain Behav Immun. 2013;33:90–101.10.1016/j.bbi.2013.06.002
   PubMed Web of Science ®Google Scholar
• Rajabi S, Hassanshahi GHH, Kazemi Arababadi M, et al. Effect of tactile learning on serum levels of IL-17 in male rats. JBUMS. 2012;14(3):25–30.
   Google Scholar
• Sun J, Zhang S, Zhang X, et al. IL-17A is implicated in lipopolysaccharide-induced neuroinflammation and cognitive impairment in aged rats via microglial activation. J Neuroinflammation. 2015 [cited 2015 Sep 15]; [12p.]. DOI:10.1186/s12974-015-0394-5.
   PubMed Web of Science ®Google Scholar
• Lyon DE, Cohen R, Chen H, et al. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer. J Neuroimmunol. 2016;301:74–82.10.1016/j.jneuroim.2016.11.002
   PubMed Web of Science ®Google Scholar
• Swardfager W, Herrmann N, Andreazza AC, et al. Poststroke neuropsychiatric symptoms: relationships with IL-17 and oxidative stress. Biomed Res Int. 2014 [2014 Jun 18]; [6p.]. DOI:10.1155/2014/245210.
   Web of Science ®Google Scholar
• Tan ZS, Beiser AS, Vasan RS, et al. Inflammatory markers and the risk of Alzheimer disease: the Framingham study. Neurology 2007;68(22):1902–1908.10.1212/01.wnl.0000263217.36439.da
   PubMed Web of Science ®Google Scholar
• Holmes C, Cunningham C, Zotova E, et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology 2009;73(10):768–774.10.1212/WNL.0b013e3181b6bb95
   PubMed Web of Science ®Google Scholar
• Trollor JN, Smith E, Agars E, et al. The association between systemic inflammation and cognitive performance in the elderly: the Sydney memory and ageing study. Age 2012;34(5):1295–1308.10.1007/s11357-011-9301-x
   PubMedGoogle Scholar
• Mooijaart SP, Sattar N, Trompet S, et al. Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study. J Intern Med. 2013;274(1):77–85.10.1111/joim.2013.274.issue-1
   PubMed Web of Science ®Google Scholar
• Menza M, Dobkin RD, Marin H, et al. The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson’s disease. Psychosomatics 2010;51:474–479.
   PubMed Web of Science ®Google Scholar
• Yaguchi T, Nagata T, Yang D, et al. Interleukin-18 regulates motor activity, anxiety and spatial learning without affecting synaptic plasticity. Behav Brain Res. 2010;206(1):47–51.10.1016/j.bbr.2009.08.033
   PubMed Web of Science ®Google Scholar
• Del Rey A, Balschun D, Wetzel W, et al. A cytokine network involving brain-borne IL-1β, IL-1ra, IL-18, IL-6, and TNFα operates during long-term potentiation and learning. Brain Behav Immun. 2013;33:15–23.10.1016/j.bbi.2013.05.011
   PubMed Web of Science ®Google Scholar
• Bellinger DL, Thyagarajan S, Lorton D, et al. Psychoneuroimmunology today: mechanisms mediating the effects of psychological status on the immune system. In: Lewis C, O’Brien RM, Barraclough J, editors. The psychoimmunology of cancer. Oxford: Oxford University Press; 2002. p. 4–62.
   Google Scholar
• Begolka WS, Miller SD. Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis. Res Immunol. 1998;149:771–781.
   PubMedGoogle Scholar
• Issazadeh S, Lorentzen JC, Mustafa MI, et al. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-β. J Neuroimmunol. 1996;69:103–115.10.1016/0165-5728(96)00076-8
   PubMed Web of Science ®Google Scholar
• Buzzard KA, Broadley SA, Butzkueven H. What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis? Int J Mol Sci. 2012;13(12):12665–12709.10.3390/ijms131012665
   PubMed Web of Science ®Google Scholar
• Simen AA, Bordner KA, Martin MP, et al. Cognitive dysfunction with aging and the role of inflammation. Ther Adv Chronic Dis. 2011;2(3):175–195.10.1177/2040622311399145
   PubMedGoogle Scholar
• Liu Q, Xin W, He P, et al.Interleukin-17 inhibits adult hippocampal neurogenesis. Sci Rep. 2014 [cited 2014 Dec 19]; [8p.]. DOI:10.1038/srep07554.
   Web of Science ®Google Scholar
• Tian A, Ma H, Zhang R, et al.Interleukin17A promotes postoperative cognitive dysfunction by triggering β-Amyloid accumulation via the transforming growth factor-β (TGFβ)/Smad signaling pathway. PLoS One. 2015 [cited 2015 Oct 28]; [18p.]. DOI:10.1371/journal.pone.0141596.
   Web of Science ®Google Scholar
• Kaneko M, Stellwagen D, Malenka RC, et al. Tumor necrosis factor-α mediates one component of competitive, experience-dependent plasticity in developing visual cortex. Neuron 2008;58:673–680.10.1016/j.neuron.2008.04.023
   PubMed Web of Science ®Google Scholar
• Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-α. Nature 2006;440:1054–1059.10.1038/nature04671
   PubMed Web of Science ®Google Scholar